Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $88.6600 (-2.54%) ($88.6600 - $88.6600) on Fri. May. 6, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.44% (three month average) | RSI | 32 | Latest Price | $88.6600(-2.54%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.8% a day on average for past five trading days. | Weekly Trend | LGND declines -3.6% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(59%) IWM(58%) IWC(55%) IWN(55%) | Factors Impacting LGND price | LGND will decline at least -1.72% in a week (0% probabilities). VIXM(-22%) UUP(-19%) VXX(-16%) TBT(-7%) UNG(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.72% (StdDev 3.44%) | Hourly BBV | -1.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $83.43(-5.9%) | Resistance Level | $98.3 | 5 Day Moving Average | $93.02(-4.69%) | 10 Day Moving Average | $93.58(-5.26%) | 20 Day Moving Average | $98.3(-9.81%) | To recent high | -29.1% | To recent low | 0% | Market Cap | $1.425b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |